In this week's Homerun Slides, we begin a new series on the role of anti-diabetes medications in reducing cardiovascular risk and outcomes in diabetes patients.

Female, 28 years of age, diagnosed with type 1 diabetes at age 25. She was taught to manage her diabetes with a basal/bolus insulin regimen and meal plan prescribed by health care team. She was taught she could eat anything she wanted as long as she covered her carbs with rapid-acting insulin. Her glucose was in control, but she gained 50 pounds over the first year. She then attributed her weight gain to taking insulin, so she would not take enough insulin to cover her glucose levels.

Type 1 indicates the processes of β-cell destruction that may ultimately lead to diabetes in which insulin is required for survival in order to prevent the development of ketoacidosis, coma, and death.

Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman, founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles, discuss the ability to predict the development of type 2 diabetes and the role A1c might play in this prediction.

56% of all diabetes patients also take medications for cholesterol and hypertension. That is an indication of why diabetes has so many complications; many are related to cardiovascular disease and many of those patients end up seeing a cardiologist. This is why we are pleased to introduce to you our new …